Novo Holdings A/S as of Dec. 31, 2019
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 29 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF (VTI) | 45.6 | $708M | 4.3M | 163.62 | |
| Inogen (INGN) | 15.6 | $243M | 3.5M | 68.33 | |
| Cable One (CABO) | 6.1 | $95M | 64k | 1488.47 | |
| Apple (AAPL) | 5.1 | $79M | 268k | 293.65 | |
| Mirum Pharmaceuticals (MIRM) | 3.9 | $60M | 2.4M | 24.52 | |
| Morphic Hldg (MORF) | 2.9 | $45M | 2.6M | 17.16 | |
| Galera Therapeutics (GRTX) | 2.9 | $45M | 3.4M | 13.16 | |
| Milestone Pharmaceuticals (MIST) | 2.5 | $39M | 2.4M | 16.01 | |
| Brookfield Asset Management | 2.5 | $39M | 673k | 57.80 | |
| Amicus Therapeutics (FOLD) | 1.4 | $23M | 2.3M | 9.74 | |
| Akebia Therapeutics (AKBA) | 1.3 | $20M | 3.1M | 6.32 | |
| Si-bone (SIBN) | 1.2 | $19M | 893k | 21.50 | |
| Aerie Pharmaceuticals | 1.0 | $16M | 670k | 24.17 | |
| Corvus Pharmaceuticals (CRVS) | 1.0 | $16M | 2.9M | 5.44 | |
| Seaspine Holdings | 1.0 | $16M | 1.3M | 12.01 | |
| Blueprint Medicines (BPMC) | 0.9 | $14M | 171k | 80.11 | |
| Inspire Med Sys (INSP) | 0.8 | $13M | 175k | 74.21 | |
| Entasis Therapeutics Holdings Ord | 0.7 | $11M | 2.2M | 4.97 | |
| Silk Road Medical Inc Common | 0.6 | $9.9M | 245k | 40.38 | |
| Flexion Therapeutics convertible security | 0.6 | $9.3M | 450k | 20.70 | |
| Spero Therapeutics (SPRO) | 0.6 | $8.9M | 931k | 9.61 | |
| Intersect Ent | 0.3 | $5.4M | 218k | 24.90 | |
| Verona Pharma Plc ads (VRNA) | 0.3 | $4.3M | 741k | 5.75 | |
| Protagonist Therapeutics (PTGX) | 0.2 | $3.4M | 479k | 7.05 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.2 | $3.4M | 135k | 25.09 | |
| Neuronetics (STIM) | 0.2 | $3.3M | 737k | 4.49 | |
| Myokardia | 0.1 | $2.2M | 30k | 72.89 | |
| Biohaven Pharmaceutical Holding | 0.1 | $2.0M | 36k | 54.43 | |
| Zogenix | 0.1 | $1.9M | 36k | 52.13 |
